Kiora Pharmaceuticals (KPRX) Assets (2014 - 2026)
Kiora Pharmaceuticals' Assets came in at $23.78 million for Q2 2026, down 25.6% from $31.95 million a year earlier but up 12.0% from the prior quarter.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Kiora Pharmaceuticals' Assets was $24.25 million, down 33.5% from FY2024.
- Assets carries a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- Going back by year, Assets was $36.48 million in FY2024 (+166.1%), $13.71 million in FY2023 (-26.6%), $18.68 million in FY2022 (-7.2%) and $20.13 million in FY2021 (+31.5%).
- The five-year range for quarterly Assets is $13.71 million (Q4 2023) to $42.44 million (Q1 2024).
- Year-over-year, Assets has declined for six consecutive quarters, with growth averaging 18.5% over the last eight quarters.
- The fastest year-over-year change in Assets over five years came in Q3 2021 (growth of 175.7%), and the weakest in Q1 2026 (a decline of 37.6%).
- Business Quant data shows KPRX's Assets at $21.23 million (Q1 2026), $24.25 million (Q4 2025) and $29.86 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 148.07 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 147.68 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 132.77 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 96.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 51.41 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 205.00 Bn |
| 10 | Kiora Pharmaceuticals | 9.08 Mn | -58.23 Mn | - | 23.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.78 Mn |
| Mar 31, 2026 | 21.23 Mn |
| Dec 31, 2025 | 24.25 Mn |
| Sep 30, 2025 | 29.86 Mn |
| Jun 30, 2025 | 31.95 Mn |
| Mar 31, 2025 | 34.02 Mn |
| Dec 31, 2024 | 36.48 Mn |
| Sep 30, 2024 | 38.51 Mn |
| Jun 30, 2024 | 40.81 Mn |
| Mar 31, 2024 | 42.44 Mn |
| Dec 31, 2023 | 13.71 Mn |
| Sep 30, 2023 | 15.90 Mn |
| Jun 30, 2023 | 19.88 Mn |
| Mar 31, 2023 | 16.53 Mn |
| Dec 31, 2022 | 18.68 Mn |
| Sep 30, 2022 | 17.66 Mn |
| Jun 30, 2022 | 15.46 Mn |
| Mar 31, 2022 | 17.64 Mn |
| Dec 31, 2021 | 20.13 Mn |
| Sep 30, 2021 | 25.49 Mn |
API Access
Kiora Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=KPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "KPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=KPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();